Literature DB >> 3627623

Whole-blood serotonin in premenstrual syndrome.

A J Rapkin, E Edelmuth, L C Chang, A E Reading, M T McGuire, T P Su.   

Abstract

Whole-blood serotonin levels in 14 subjects with well documented premenstrual syndrome and 13 age-matched controls were compared. Serotonin levels of premenstrual syndrome subjects were significantly lower during the last ten days of the menstrual cycle. No significant differences were noted in levels of serum estradiol and progesterone. Decreased serotonin is known to be associated with depression in humans, and nonhuman primates have exhibited abnormal behavioral profiles when given serotonin antagonists. The present observation suggests that the physiologic basis of premenstrual syndrome involves an alteration in serotonin metabolism.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3627623

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  21 in total

Review 1.  The pathophysiologic background for current treatments of premenstrual syndromes.

Authors:  Uriel Halbreich
Journal:  Curr Psychiatry Rep       Date:  2002-12       Impact factor: 5.285

Review 2.  The role of central serotonergic dysfunction in the aetiology of premenstrual dysphoric disorder: therapeutic implications.

Authors:  B L Parry
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 3.  Premenstrual Dysphoric Disorder: Epidemiology and Treatment.

Authors:  Liisa Hantsoo; C Neill Epperson
Journal:  Curr Psychiatry Rep       Date:  2015-11       Impact factor: 5.285

4.  Premenstrual dysphoric disorder and the brain.

Authors:  C Neill Epperson
Journal:  Am J Psychiatry       Date:  2013-03       Impact factor: 18.112

5.  Sleep, Hormones, and Circadian Rhythms throughout the Menstrual Cycle in Healthy Women and Women with Premenstrual Dysphoric Disorder.

Authors:  Ari Shechter; Diane B Boivin
Journal:  Int J Endocrinol       Date:  2010-01-18       Impact factor: 3.257

6.  Alteration of 5-HT uptake by plasma fractions in the premenstrual syndrome.

Authors:  C R Ashby; L A Carr; C L Cook; M M Steptoe; D D Franks
Journal:  J Neural Transm Gen Sect       Date:  1990

Review 7.  Luteal phase administration of agents for the treatment of premenstrual dysphoric disorder.

Authors:  Ellen W Freeman
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 8.  Reproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability?

Authors:  Claudio N Soares; Brook Zitek
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186

Review 9.  A risk-benefit appraisal of drugs used in the management of premenstrual syndrome.

Authors:  J F Mortola
Journal:  Drug Saf       Date:  1994-02       Impact factor: 5.606

10.  Premenstrual Dysphoric Disorder: Recognition and Treatment.

Authors:  Ellen W. Freeman; Steven J. Sondheimer
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2003-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.